Wall Street Zen Downgrades Nutex Health (NASDAQ:NUTX) to Hold

Nutex Health (NASDAQ:NUTX) was downgraded by stock analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued to investors on Saturday, Wall Street Zen reports.

NUTX has been the subject of several other reports. Lake Street Capital reaffirmed a “buy” rating and issued a $310.00 target price (up from $235.00) on shares of Nutex Health in a report on Tuesday, August 11th. Weiss Ratings raised Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research report on Tuesday, July 28th. Zacks Research upgraded Nutex Health from a “hold” rating to a “strong-buy” rating in a research note on Monday, August 24th. B. Riley Financial raised their target price on Nutex Health from $290.00 to $325.00 and gave the company a “buy” rating in a research report on Friday. Finally, B Riley reiterated a “buy” rating on shares of Nutex Health in a research note on Friday. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, Nutex Health presently has a consensus rating of “Buy” and a consensus price target of $317.50.

Nutex Health Price Performance

NUTX opened at $193.24 on Friday. Nutex Health has a fifty-two week low of $80.53 and a fifty-two week high of $204.00. The firm has a market capitalization of $1.32 billion, a P/E ratio of 7.59 and a beta of 0.28. The company’s 50-day moving average is $175.59 and its 200 day moving average is $137.01. The company has a debt-to-equity ratio of 0.59, a current ratio of 5.00 and a quick ratio of 4.96.

Nutex Health (NASDAQ:NUTX) last issued its quarterly earnings data on Thursday, August 6th. The company reported $9.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.95 by $4.43. Nutex Health had a net margin of 21.25% and a return on equity of 39.74%. The business had revenue of $210.75 million during the quarter, compared to the consensus estimate of $215.03 million.

Institutional Trading of Nutex Health

A number of large investors have recently bought and sold shares of the company. California State Teachers Retirement System raised its stake in shares of Nutex Health by 25,615.8% in the second quarter. California State Teachers Retirement System now owns 934,768 shares of the company’s stock valued at $159,743,000 after buying an additional 931,133 shares during the period. BlackRock Inc. bought a new position in shares of Nutex Health during the 2nd quarter worth $69,612,000. Pertento Partners LLP increased its holdings in Nutex Health by 20.0% in the 4th quarter. Pertento Partners LLP now owns 324,422 shares of the company’s stock worth $53,406,000 after acquiring an additional 54,001 shares during the last quarter. Topline Capital Management LLC increased its holdings in Nutex Health by 72.0% in the 2nd quarter. Topline Capital Management LLC now owns 309,131 shares of the company’s stock worth $38,484,000 after acquiring an additional 129,418 shares during the last quarter. Finally, Vanguard Group Inc. raised its stake in Nutex Health by 12.7% in the 3rd quarter. Vanguard Group Inc. now owns 214,954 shares of the company’s stock valued at $22,209,000 after acquiring an additional 24,275 shares during the period. 5.32% of the stock is owned by hedge funds and other institutional investors.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.